These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35209126)

  • 1. Synthesis and Structure-Activity Relationship Studies of Benzimidazole-4,7-dione-Based P2X3 Receptor Antagonists as Novel Anti-Nociceptive Agents.
    Bae J; Kim YO; Han X; Yoon MH; Kim WM; Kim YC
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Potent Antiallodynic Agents for Neuropathic Pain Targeting P2X3 Receptors.
    Jung YH; Kim YO; Lin H; Cho JH; Park JH; Lee SD; Bae J; Kang KM; Kim YG; Pae AN; Ko H; Park CS; Yoon MH; Kim YC
    ACS Chem Neurosci; 2017 Jul; 8(7):1465-1478. PubMed ID: 28323403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 1: Initial structure-activity relationship studies of a hit from a high throughput screening.
    Tobinaga H; Kameyama T; Oohara M; Kobayashi N; Ohdan M; Ishizuka N; Kume M; Tomari M; Tanaka Y; Takahashi F; Kinoshita H; Shimada S; Shinohara S; Kai H
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2338-2342. PubMed ID: 29805055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dioxotriazine derivatives as a new class of P2X
    Kai H; Horiguchi T; Kameyama T; Asahi K; Endoh T; Jikihara S; Hasegawa T; Tanaka S; Nozu A; Takeyama C; Tomari M; Takahashi F; Tamura N; Yagi S; Itoh T; Isou Y
    Bioorg Med Chem Lett; 2021 Apr; 37():127833. PubMed ID: 33540044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration.
    Garceau D; Chauret N
    Pulm Pharmacol Ther; 2019 Jun; 56():56-62. PubMed ID: 30902655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonists.
    Kai H; Horiguchi T; Kameyma T; Onodera N; Itoh N; Fujii Y; Ichihashi Y; Hirai K; Shintani T; Nakamura K; Minami K; Kasai E; Yoneda S; Murakami Y; Ogawa H; Sekimoto R; Shinohara S; Yoshida O; Kurose N
    Bioorg Med Chem Lett; 2021 Nov; 52():128384. PubMed ID: 34587541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 5-methyl-1H-benzo[d]imidazole derivatives as novel P2X3 Receptor antagonists.
    Bae J; Kang KM; Kim YC
    Bioorg Med Chem Lett; 2022 Sep; 72():128820. PubMed ID: 35644300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds.
    Szántó G; Makó A; Bata I; Farkas B; Kolok S; Vastag M; Cselenyák A
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3896-904. PubMed ID: 27423478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 3: Structure-activity relationships of pyrropyrazolone derivatives.
    Tobinaga H; Kameyama T; Asahi K; Horiguchi T; Oohara M; Taoda Y; Hata K; Hasegawa T; Tada Y; Kurihara N; Kanda Y; Yagi S; Tomari M; Tanaka Y; Takahashi F; Taniguchi E; Takahara Y; Shimada S; Takeyama C; Yamamoto S; Shinohara S; Kai H
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127636. PubMed ID: 33132115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X3 receptor mediates heat hyperalgesia in a rat model of trigeminal neuropathic pain.
    Shinoda M; Kawashima K; Ozaki N; Asai H; Nagamine K; Sugiura Y
    J Pain; 2007 Jul; 8(7):588-97. PubMed ID: 17481957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine derivatives with P2X4 receptor-blocking activity.
    Tian M; Abdelrahman A; Weinhausen S; Hinz S; Weyer S; Dosa S; El-Tayeb A; Müller CE
    Bioorg Med Chem; 2014 Feb; 22(3):1077-88. PubMed ID: 24411477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of second-generation P2X3 antagonists for treatment of pain.
    Ginnetti AT; Paone DV; Stauffer SR; Potteiger CM; Shaw AW; Deng J; Mulhearn JJ; Nguyen DN; Segerdell C; Anquandah J; Calamari A; Cheng G; Leitl MD; Liang A; Moore E; Panigel J; Urban M; Wang J; Fillgrove K; Tang C; Cook S; Kane S; Salvatore CA; Graham SL; Burgey CS
    Bioorg Med Chem Lett; 2018 May; 28(8):1392-1396. PubMed ID: 29548573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New P2X3 receptor antagonists. Part 2: Identification and SAR of quinazolinones.
    Szántó G; Makó A; Vágó I; Hergert T; Bata I; Farkas B; Kolok S; Vastag M
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3905-12. PubMed ID: 27426300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors with in vivo efficacy in a pain model.
    Ballini E; Virginio C; Medhurst SJ; Summerfield SG; Aldegheri L; Buson A; Carignani C; Chen YH; Giacometti A; Lago I; Powell AJ; Jarolimek W
    Br J Pharmacol; 2011 Jul; 163(6):1315-25. PubMed ID: 21410458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the Purinergic Receptor Subtype P2X3 in the Trigeminal Ganglion Is Involved in Orofacial Pain Induced by Occlusal Interference in Rats.
    Qi D; Yang Y; Ji P; Kong J; Wu Q; Si H
    J Oral Facial Pain Headache; 2016; 30(1):51-60. PubMed ID: 26817033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents.
    Dal Ben D; Marchenkova A; Thomas A; Lambertucci C; Spinaci A; Marucci G; Nistri A; Volpini R
    Purinergic Signal; 2017 Mar; 13(1):61-74. PubMed ID: 27757785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
    Park JH; Lee GE; Lee SD; Ko H; Kim YC
    Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
    Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
    Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications.
    Marucci G; Dal Ben D; Buccioni M; Martí Navia A; Spinaci A; Volpini R; Lambertucci C
    Expert Opin Ther Pat; 2019 Dec; 29(12):943-963. PubMed ID: 31726893
    [No Abstract]   [Full Text] [Related]  

  • 20. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.
    Jarvis MF; Burgard EC; McGaraughty S; Honore P; Lynch K; Brennan TJ; Subieta A; Van Biesen T; Cartmell J; Bianchi B; Niforatos W; Kage K; Yu H; Mikusa J; Wismer CT; Zhu CZ; Chu K; Lee CH; Stewart AO; Polakowski J; Cox BF; Kowaluk E; Williams M; Sullivan J; Faltynek C
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17179-84. PubMed ID: 12482951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.